Trapani, A.; Cometa, S.; De Giglio, E.; Corbo, F.; Cassano, R.; Di Gioia, M.L.; Trombino, S.; Hossain, M.N.; Di Gioia, S.; Trapani, G.;
et al. Novel Nanoparticles Based on N,O-Carboxymethyl Chitosan-Dopamine Amide Conjugate for Nose-to-Brain Delivery. Pharmaceutics 2022, 14, 147.
https://doi.org/10.3390/pharmaceutics14010147
AMA Style
Trapani A, Cometa S, De Giglio E, Corbo F, Cassano R, Di Gioia ML, Trombino S, Hossain MN, Di Gioia S, Trapani G,
et al. Novel Nanoparticles Based on N,O-Carboxymethyl Chitosan-Dopamine Amide Conjugate for Nose-to-Brain Delivery. Pharmaceutics. 2022; 14(1):147.
https://doi.org/10.3390/pharmaceutics14010147
Chicago/Turabian Style
Trapani, Adriana, Stefania Cometa, Elvira De Giglio, Filomena Corbo, Roberta Cassano, Maria Luisa Di Gioia, Sonia Trombino, Md Niamat Hossain, Sante Di Gioia, Giuseppe Trapani,
and et al. 2022. "Novel Nanoparticles Based on N,O-Carboxymethyl Chitosan-Dopamine Amide Conjugate for Nose-to-Brain Delivery" Pharmaceutics 14, no. 1: 147.
https://doi.org/10.3390/pharmaceutics14010147
APA Style
Trapani, A., Cometa, S., De Giglio, E., Corbo, F., Cassano, R., Di Gioia, M. L., Trombino, S., Hossain, M. N., Di Gioia, S., Trapani, G., & Conese, M.
(2022). Novel Nanoparticles Based on N,O-Carboxymethyl Chitosan-Dopamine Amide Conjugate for Nose-to-Brain Delivery. Pharmaceutics, 14(1), 147.
https://doi.org/10.3390/pharmaceutics14010147